Novavax to Present at the 15th Annual Needham Healthcare Conference
April 06 2016 - 4:05PM
GAITHERSBURG, Md., April 06, 2016
(GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) a clinical-stage
vaccine company focused on the discovery, development and
commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced Stanley C. Erck, President and Chief
Executive Officer, will present at the 15th Annual
Needham Healthcare Conference.
Conference details are as
follows:
Date: Wednesday, April 13,
2016
Time: 8:40 a.m. U.S. Eastern Time
Location: Westin Grand Central hotel, New York City
Live webcast: http://wsw.com/webcast/needham76/nvax
The webcast and a replay of the
presentation will also be accessible under the "Investors/Events"
section of the Novavax website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a
clinical-stage vaccine company committed to delivering novel
products to prevent a broad range of infectious diseases. Its
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are
the foundation for ground-breaking innovation that improves global
health through safe and effective vaccines. Additional information
about Novavax is available on the company's
website, novavax.com.
Contact: Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
HUG#2000927
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024